Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Non-Current Assets (2016 - 2025)

Vycor Medical has reported Non-Current Assets over the past 16 years, most recently at $266998.0 for Q4 2025.

  • Quarterly Non-Current Assets fell 29.46% to $266998.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, down 16.17% year-over-year, with the annual reading at $266998.0 for FY2025, 29.46% down from the prior year.
  • Non-Current Assets was $266998.0 for Q4 2025 at Vycor Medical, down from $278599.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $521447.0 in Q1 2021 and troughed at $266998.0 in Q4 2025.
  • The 5-year median for Non-Current Assets is $374262.5 (2022), against an average of $378495.0.
  • Year-over-year, Non-Current Assets grew 23.13% in 2024 and then decreased 29.46% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $447953.0 in 2021, then fell by 23.56% to $342415.0 in 2022, then rose by 19.21% to $408208.0 in 2023, then decreased by 7.28% to $378503.0 in 2024, then decreased by 29.46% to $266998.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Non-Current Assets are $266998.0 (Q4 2025), $278599.0 (Q3 2025), and $324591.0 (Q2 2025).